Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Sigma-1 receptor and inflammatory pain.

Gris G, Cobos EJ, Zamanillo D, Portillo-Salido E.

Inflamm Res. 2015 Jun;64(6):377-81. doi: 10.1007/s00011-015-0819-8. Epub 2015 Apr 23.

PMID:
25902777
2.

Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.

Colombo M, Mirandola L, Reidy A, Suvorava N, Konala V, Chiaramonte R, Grizzi F, Rahman RL, Jenkins MR, Nugyen DD, Dalhbeck S, Cobos E, Figueroa JA, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):188-99. doi: 10.3109/08830185.2015.1027629.

PMID:
25901861
3.

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, R Jenkins M, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419.

PMID:
25901860
4.

Cancer-testis antigens and immunotherapy in the light of cancer complexity.

Grizzi F, Mirandola L, Qehajaj D, Cobos E, Figueroa JA, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):143-53. doi: 10.3109/08830185.2015.1018418.

PMID:
25901859
5.

Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium.

Mirandola L, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M.

Int Rev Immunol. 2015 Mar;34(2):134-42. doi: 10.3109/08830185.2015.1018417.

PMID:
25901858
6.

The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.

Luna-Sánchez M, Díaz-Casado E, Barca E, Tejada MÁ, Montilla-García Á, Cobos EJ, Escames G, Acuña-Castroviejo D, Quinzii CM, López LC.

EMBO Mol Med. 2015 Mar 23;7(5):670-87. doi: 10.15252/emmm.201404632.

7.

Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.

Mirandola L, Figueroa JA, Phan TT, Grizzi F, Kim M, Rahman RL, Jenkins MR, Cobos E, Jumper C, Alalawi R, Chiriva-Internati M.

Oncotarget. 2015 Feb 20;6(5):2812-26.

8.

Correction: Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity.

Chiu IM, Barrett LB, Williams EK, Strochlic DE, Lee S, Weyer AD, Lou S, Bryman G, Roberson DP, Ghasemlou N, Piccoli C, Ahat E, Wang V, Cobos EJ, Stucky CL, Ma Q, Liberles SD, Woolf C.

Elife. 2015 Feb 6;4:e06720. doi: 10.7554/eLife.06720. No abstract available.

9.

WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.

Iglesias-Bexiga M, Castillo F, Cobos ES, Oka T, Sudol M, Luque I.

PLoS One. 2015 Jan 21;10(1):e0113828. doi: 10.1371/journal.pone.0113828. eCollection 2015.

10.

Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity.

Chiu IM, Barrett LB, Williams EK, Strochlic DE, Lee S, Weyer AD, Lou S, Bryman GS, Roberson DP, Ghasemlou N, Piccoli C, Ahat E, Wang V, Cobos EJ, Stucky CL, Ma Q, Liberles SD, Woolf CJ.

Elife. 2014 Dec 19;3. doi: 10.7554/eLife.04660. Erratum in: Elife. 2015 Jan 15;4:e06720.

11.

Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.

Crespillo S, Cámara-Artigas A, Casares S, Morel B, Cobos ES, Mateo PL, Mouz N, Martin CE, Roger MG, El Habib R, Su B, Moog C, Conejero-Lara F.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18207-12. doi: 10.1073/pnas.1413592112. Epub 2014 Dec 8.

12.

Galectins in cancer: carcinogenesis, diagnosis and therapy.

Ebrahim AH, Alalawi Z, Mirandola L, Rakhshanda R, Dahlbeck S, Nguyen D, Jenkins M, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M.

Ann Transl Med. 2014 Sep;2(9):88. doi: 10.3978/j.issn.2305-5839.2014.09.12. Review.

13.

Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Pena C, Mirandola L, Figueroa JA, Hosiriluck N, Suvorava N, Trotter K, Reidy A, Rakhshanda R, Payne D, Jenkins M, Grizzi F, Littlefield L, Chiriva-Internati M, Cobos E.

Ann Transl Med. 2014 Sep;2(9):87. doi: 10.3978/j.issn.2305-5839.2014.09.14. Review.

14.

Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.

Mirandola L, Yu Y, Cannon MJ, Jenkins MR, Rahman RL, Nguyen DD, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M.

Gynecol Oncol. 2014 Dec;135(3):573-9. doi: 10.1016/j.ygyno.2014.09.021. Epub 2014 Oct 6.

PMID:
25284038
15.

AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet.

Zhu H, Cao M, Figueroa JA, Cobos E, Uretsky BF, Chiriva-Internati M, Hermonat PL.

J Transl Med. 2014 Sep 20;12:252. doi: 10.1186/s12967-014-0252-8.

16.

Autofluorescence and axial length as prognostic factors for outcomes of macular hole retinal detachment surgery in high myopia.

Arias L, Caminal JM, Rubio MJ, Cobos E, Garcia-Bru P, Filloy A, Padron N, Mejia K.

Retina. 2015 Mar;35(3):423-8. doi: 10.1097/IAE.0000000000000335.

PMID:
25170859
17.

Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration.

Painter MW, Brosius Lutz A, Cheng YC, Latremoliere A, Duong K, Miller CM, Posada S, Cobos EJ, Zhang AX, Wagers AJ, Havton LA, Barres B, Omura T, Woolf CJ.

Neuron. 2014 Jul 16;83(2):331-43. doi: 10.1016/j.neuron.2014.06.016.

PMID:
25033179
18.

The impact of extra-domain structures and post-translational modifications in the folding/misfolding behaviour of the third PDZ domain of MAGUK neuronal protein PSD-95.

Murciano-Calles J, Marin-Argany M, Cobos ES, Villegas S, Martinez JC.

PLoS One. 2014 May 20;9(5):e98124. doi: 10.1371/journal.pone.0098124. eCollection 2014.

19.

Selective expression and immunogenicity of the cancer/testis antigens SP17, AKAP4 and PTTG1 in non-small cell lung cancer: new candidates for active immunotherapy.

Chiriva-Internati M, Mirandola L, Figueroa JA, Yu Y, Grizzi F, Kim M, Jenkins M, Cobos E, Jumper C, Alalawi R.

Chest. 2014 May 8. doi: 10.1378/chest.13-0770. [Epub ahead of print]

PMID:
24811938
20.

The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review.

Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, Jenkins M, Chiriva-Internati M, Cobos E.

Int Rev Immunol. 2014 Oct;33(5):383-401. doi: 10.3109/08830185.2014.911857. Epub 2014 May 8.

PMID:
24811210
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk